Related Experiment Video

Updated: Jul 17, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.9K

Review article: the management of cirrhosis in women

A M Allen1, J E Hay

  • 1Hepatology and Liver Transplantation, Mayo Clinic, Rochester, MN, USA.

Alimentary Pharmacology & Therapeutics
|September 30, 2014
PubMed

Insights

Women with chronic liver disease face unique challenges, including increased risks from smoking and unique considerations for fertility and pregnancy management. Their care requires tailored approaches beyond standard protocols.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Women's Health

Background:

  • Significant differences exist in the predisposition, disease progression, complications, and treatment outcomes of liver disease between men and women.
  • These sex-based disparities necessitate a specialized approach to managing chronic liver conditions.

Purpose of the Study:

  • To comprehensively review the clinical distinctions in cirrhosis between male and female patients.
  • To address the specific management issues related to fertility, pregnancy, and contraception in women with cirrhosis.

Main Methods:

  • A systematic literature search was conducted using PubMed and MEDLINE.
  • Keywords included 'cirrhosis,' 'chronic liver disease,' specific liver diseases, 'cancer,' 'hepatocellular carcinoma,' 'smoking,' 'liver transplantation,' 'metabolic bone disease,' 'fertility,' 'pregnancy,' and 'contraception.'

Main Results:

  • Pre-menopausal status offers protection against viral hepatitis C and non-alcoholic steatohepatitis.
  • Smoking, particularly with alcohol, is a greater risk factor for cirrhosis and malignancies in women, though they are less prone to hepatocellular carcinoma.
  • Women with cirrhosis exhibit more osteopenic bone disease, requiring active management, and face higher maternal/fetal risks during pregnancy, primarily from variceal bleeding.

Conclusions:

  • The management of women with chronic liver disease is distinct, particularly concerning counseling, complication screening, fertility, and pregnancy.
  • Current organ allocation systems, like the MELD score, may disadvantage women due to factors such as body size.
Abstract

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

7.2K
Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

1.0K

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...